Optimi Health Resolves Dispute
10 November 2023 - 1:30PM
Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) ("Optimi"
or the "Company") is pleased to announce the successful resolution
of a dispute that arose in connection with a termination notice
related to a supply agreement ("the Supply Agreement") signed with
a private entity on May 4, 2023.
Optimi is pleased to confirm that the dispute
has been amicably resolved and the Supply Agreement has been
terminated through a negotiated settlement.
This resolution underscores Optimi's commitment
to maintaining positive relationships with its partners while
upholding its business integrity. The Company remains dedicated to
delivering on its mission of providing high-quality drug candidates
and services in the psychedelics sector.
For more information, please contact Michael
Kydd at:
investors@optimihealth.ca 902.880.6121
www.optimihealth.ca
ABOUT OPTIMI (CSE: OPTI) (OTCQX: OPTHF) (FRA:
8BN)
Optimi Health Corp. an end-to-end drug
researcher and formulator licensed by Health Canada to produce and
supply, for clinical research purposes, psychedelic substances such
as 3,4-Methylenedioxymethamphetamine (“MDMA”), natural GMP-grade
psilocybin, as well as functional mushrooms that focus on the
health and wellness markets. Built with the purpose of producing
scalable psychedelic formulations for transformational human
experiences, the Company’s goal is to be the number one trusted,
compassionate supplier of safe drug products throughout the world.
Optimi’s products are grown and manufactured at its two facilities
comprising a total of 20,000 square feet in Princeton, British
Columbia.
FORWARD‐LOOKING
STATEMENTS
This news release contains forward-looking
statements and forward-looking information within the meaning of
Canadian securities legislation (collectively, “forward-looking
statements”) that relate to Optimi’s current expectations and views
of future events. Any statements that express, or involve
discussions as to, expectations, beliefs, plans, objectives,
assumptions or future events or performance (often, but not always,
through the use of words or phrases such as “will likely result,”
“are expected to,” “expects,” “will continue,” “is anticipated,”
“anticipates,” “believes,” “estimated,” “intends,” “plans,”
“forecast,” “projection,” “strategy,” “objective,” and “outlook”)
are not historical facts and may be forward-looking statements and
may involve estimates, assumptions and uncertainties which could
cause actual results or outcomes to differ materially from those
expressed in such forward-looking statements. No assurance can be
given that these expectations will prove to be correct and such
forward-looking statements included in this news release should not
be unduly relied upon. These statements speak only as of the date
of this news release.
Forward-looking statements are based on a number
of assumptions and are subject to a number of risks and
uncertainties, many of which are beyond Optimi’s control, which
could cause actual results and events to differ materially from
those that are disclosed in or implied by such forward-looking
statements. Such risks and uncertainties include, but are not
limited to, the impact and progression of the COVID-19 pandemic and
other factors set forth under “Forward-Looking Statements” and
“Risk Factors” in the Company’s Annual Information Form dated
January 9, 2023, and other continuous disclosure filings available
under Optimi’s profile at www.sedarplus.ca. Optimi undertakes no
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise,
except as may be required by law. New factors emerge from time to
time, and it is not possible for Optimi to predict all of them or
assess the impact of each such factor or the extent to which any
factor, or combination of factors, may cause results to differ
materially from those contained in any forward-looking
statement.
Any forward-looking statements contained in this
news release are expressly qualified in their entirety by this
cautionary statement.
Optimi Health (TG:8BN)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Optimi Health (TG:8BN)
Historical Stock Chart
Von Jun 2023 bis Jun 2024